PMS has been a legitimate diagnosis for several decades, but there are no FDA-approved therapies for it. Off-label use of medications that are FDA-approved for PMDD is common in clinical practice. For patients taking daily SSRIs for anxiety or mood symptoms, premenstrual dose adjustment offers a novel management strategy.
Developing a program for addressing social determinants of health
February 8th 2024Explore the role of health care professionals in enhancing women's health by integrating systematic strategies to address social determinants, leveraging screening tools, and embracing data analytics for personalized care and improved outcomes.
Read More